Blue Barn Wealth LLC Boosts Stock Holdings in Haleon plc (NYSE:HLN)

Blue Barn Wealth LLC increased its position in shares of Haleon plc (NYSE:HLN) by 7.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 20,858 shares of the company’s stock after buying an additional 1,425 shares during the period. Blue Barn Wealth LLC’s holdings in Haleon were worth $172,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp raised its stake in shares of Haleon by 71.3% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,495,001 shares of the company’s stock worth $12,453,000 after buying an additional 622,041 shares during the period. Brown Advisory Inc. increased its stake in shares of Haleon by 9.8% during the third quarter. Brown Advisory Inc. now owns 36,323 shares of the company’s stock worth $303,000 after purchasing an additional 3,233 shares in the last quarter. Park Avenue Securities LLC raised its position in shares of Haleon by 12.8% during the 3rd quarter. Park Avenue Securities LLC now owns 91,880 shares of the company’s stock worth $765,000 after purchasing an additional 10,431 shares during the last quarter. Keel Point LLC purchased a new position in Haleon in the 3rd quarter valued at about $98,000. Finally, First Horizon Advisors Inc. lifted its stake in Haleon by 53.4% in the 3rd quarter. First Horizon Advisors Inc. now owns 14,478 shares of the company’s stock valued at $121,000 after buying an additional 5,038 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Trading Up 1.1 %

Shares of HLN stock traded up $0.09 during trading on Tuesday, hitting $8.33. 5,294,188 shares of the stock traded hands, compared to its average volume of 5,482,099. The firm has a market capitalization of $38.04 billion, a P/E ratio of 27.48, a price-to-earnings-growth ratio of 2.19 and a beta of 0.28. Haleon plc has a 52-week low of $7.70 and a 52-week high of $8.98. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.04 and a quick ratio of 0.73. The firm’s fifty day moving average price is $8.33 and its 200-day moving average price is $8.29.

Haleon Announces Dividend

The firm also recently disclosed a semi-annual dividend, which will be paid on Thursday, May 16th. Investors of record on Friday, March 15th will be given a dividend of $0.1064 per share. This represents a dividend yield of 1.8%. The ex-dividend date of this dividend is Thursday, March 14th. Haleon’s payout ratio is 70.00%.

Analyst Upgrades and Downgrades

HLN has been the subject of several research reports. Argus reiterated a “buy” rating on shares of Haleon in a research report on Tuesday, March 26th. HSBC initiated coverage on Haleon in a report on Wednesday, April 17th. They set a “buy” rating on the stock. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy”.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.